Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-04, with 37 holding rows worth $564,615,000.

Accession
0001567619-21-014386
Filed
2021-08-04
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, 37 entries on the cover page, a total value of $564,615,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $564,615,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Pfizer Inc.717081103COM1,139,985$44,642,000thousands by filing date
Gilead Sciences,Inc.375558103COM577,368$39,758,000thousands by filing date
Merck & Co.,Inc.58933Y105COM455,447$35,420,000thousands by filing date
Bristol-Myers Squibb Company110122108COM523,493$34,980,000thousands by filing date
Medtronic PlcG5960L103COM209,128$25,959,000thousands by filing date
BIOGEN INC COM09062X103Stock73,043$25,293,000thousands by filing date
INCYTE CORP COM45337C102Stock284,145$23,905,000thousands by filing date
BRUKER CORP116794108COM306,650$23,299,000thousands by filing date
BECTON DICKINSON & CO075887109COM94,681$23,025,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM368,931$21,062,000thousands by filing date
NUVASIVE INC670704105COM293,754$19,911,000thousands by filing date
Boston Scientific Corporation101137107COM436,406$18,661,000thousands by filing date
Elevance Health, Inc.036752103COM44,624$17,037,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock229,410$16,731,000thousands by filing date
CVS Health Corporation126650100COM200,441$16,725,000thousands by filing date
ORGANON & CO COMMON STOCK68622V106Stock552,232$16,711,000thousands by filing date
BAXTER INTL INC071813109COM192,739$15,515,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock396,478$13,754,000thousands by filing date
SCHEIN HENRY INC806407102COM165,721$12,295,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW43,547$12,012,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock263,488$10,511,000thousands by filing date
REVVITY INC714046109COM67,661$10,448,000thousands by filing date
BIO RAD LABS INC090572207CL A16,136$10,396,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock58,017$9,835,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock204,732$9,387,000thousands by filing date
HOLOGIC INC436440101COM117,738$7,855,000thousands by filing date
QIAGEN NVN72482123SHS NEW160,061$7,744,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,705,553$7,402,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM68,964$5,754,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM90,738$5,155,000thousands by filing date
Johnson & Johnson478160104COM30,000$4,942,000thousands by filing date
PATTERSON COS INC703395103COM141,743$4,308,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock29,211$4,277,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock234,916$3,045,000thousands by filing date
NOVAVAX INC670002401COM NEW13,626$2,893,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock4,876$2,723,000thousands by filing date
LIVANOVA PLCG5509L101SHS14,803$1,245,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-21-014386this filing2021-08-04acceptance time not in the bulk data set